[{"indications": "Indications\u00a0severe inflammatory skin disorders such as eczemas\r\nunresponsive to less potent corticosteroids; psoriasis,\r\n\n(From 13.4 Topical corticosteroids: British National Formulary)\n13.4 Topical corticosteroids", "name": "BETAMETHASONE ESTERS With antimicrobials", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.4 Topical corticosteroids", "BETAMETHASONE ESTERS", "With antimicrobials"], "cautions": "Cautions\u00a0\n(From 13.4 Topical corticosteroids: British National Formulary)\nCautions\u00a0Avoid prolonged use of a topical corticosteroid on the face (and keep away from eyes). In children avoid prolonged use and use potent or very potent corticosteroids under specialist supervision; extreme caution is required in dermatoses of infancy including nappy rash\u2014treatment should be limited to 5\u20137 days.Psoriasis\u00a0The use of potent or very potent corticosteroids in psoriasis can result in rebound relapse, development of generalised pustular psoriasis, and local and systemic toxicity.; use of more than 100\u00a0g per week\r\nof 0.1% preparation likely to cause adrenal suppression", "side-effects": "Side-effects\u00a0\n(From 13.4 Topical corticosteroids: British National Formulary)\nSide-effects\u00a0Mild and moderately potent topical corticosteroids are associated with few side-effects but care is required in the use of potent and very potent corticosteroids. Absorption through the skin can rarely cause adrenal suppression and even Cushing\u2019s syndrome (section 6.3.2), depending on the area of the body being treated and the duration of treatment. Absorption is greatest where the skin is thin or raw, and from intertriginous areas; it is increased by occlusion. Local side-effects include:spread and worsening of untreated infection;thinning of the skin which may be restored over a period after stopping treatment but the original structure may never return;irreversible striae atrophicae and telangiectasia;contact dermatitis;perioral dermatitis;acne, or worsening of acne or rosacea;mild depigmentation which may be reversible;hypertrichosis also reported.In order to minimise the side-effects of a topical corticosteroid, it is important to apply it thinly to affected areas only, no more frequently than twice daily, and to use the least potent formulation which is fully effective.", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5886.htm", "doses": ["Apply thinly 1\u20132 times daily", "Name[Fucibet\u00ae (LEO) ] Cream, betamethasone (as valerate) 0.1%, fusidic acid 2%, net price\r\n30\u00a0g = \u00a35.29, 60\u00a0g = \u00a310.58. \r\n    Label:\r\n    28, counselling, application. Potency: potentExcipients  include cetostearyl\r\nalcohol, chlorocresol\nLipid cream, betamethasone (as valerate)\r\n0.1%, fusidic acid 2%, net price 30\u00a0g = \u00a35.62. \r\n    Label:\r\n    28, counselling, application. Potency: potentExcipients  include cetostearyl alcohol, hydroxybenzoates\r\n(parabens)"]}, {"indications": "Indications\u00a0severe inflammatory skin disorders such as eczemas\r\nunresponsive to less potent corticosteroids; psoriasis,\r\n\n(From 13.4 Topical corticosteroids: British National Formulary)\n13.4 Topical corticosteroids", "name": "BETAMETHASONE ESTERS With salicylic acid", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.4 Topical corticosteroids", "BETAMETHASONE ESTERS", "With salicylic acid"], "cautions": "Cautions\u00a0\n(From 13.4 Topical corticosteroids: British National Formulary)\nCautions\u00a0Avoid prolonged use of a topical corticosteroid on the face (and keep away from eyes). In children avoid prolonged use and use potent or very potent corticosteroids under specialist supervision; extreme caution is required in dermatoses of infancy including nappy rash\u2014treatment should be limited to 5\u20137 days.Psoriasis\u00a0The use of potent or very potent corticosteroids in psoriasis can result in rebound relapse, development of generalised pustular psoriasis, and local and systemic toxicity.; use of more than 100\u00a0g per week\r\nof 0.1% preparation likely to cause adrenal suppression", "side-effects": "Side-effects\u00a0\n(From 13.4 Topical corticosteroids: British National Formulary)\nSide-effects\u00a0Mild and moderately potent topical corticosteroids are associated with few side-effects but care is required in the use of potent and very potent corticosteroids. Absorption through the skin can rarely cause adrenal suppression and even Cushing\u2019s syndrome (section 6.3.2), depending on the area of the body being treated and the duration of treatment. Absorption is greatest where the skin is thin or raw, and from intertriginous areas; it is increased by occlusion. Local side-effects include:spread and worsening of untreated infection;thinning of the skin which may be restored over a period after stopping treatment but the original structure may never return;irreversible striae atrophicae and telangiectasia;contact dermatitis;perioral dermatitis;acne, or worsening of acne or rosacea;mild depigmentation which may be reversible;hypertrichosis also reported.In order to minimise the side-effects of a topical corticosteroid, it is important to apply it thinly to affected areas only, no more frequently than twice daily, and to use the least potent formulation which is fully effective.", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5882.htm", "doses": ["Apply thinly 1\u20132 times daily", "apply a few drops 1\u20132 times daily", "Name[Diprosalic\u00ae (Schering-Plough) ] Ointment, betamethasone (as dipropionate) 0.05%, salicylic acid 3%, net\r\nprice 30\u00a0g = \u00a33.18, 100\u00a0g = \u00a39.14. \r\n    Label:\r\n    28, counselling, application. Potency: potent Excipients  none as listed in section 13.1.3Dose\u00a0apply thinly 1\u20132 times daily; max. 60\u00a0g per week\nScalp application, betamethasone (as dipropionate) 0.05%, salicylic acid 2%, in\r\nan alcoholic basis, net price 100\u00a0mL = \u00a310.10. \r\n    Label:\r\n    28, counselling, application. Potency: potentExcipients  include disodium\r\nedetateDose\u00a0apply a few drops 1\u20132 times daily"]}, {"indications": "Indications\u00a0severe inflammatory skin disorders such as eczemas\r\nunresponsive to less potent corticosteroids; psoriasis,\r\n\n(From 13.4 Topical corticosteroids: British National Formulary)\n13.4 Topical corticosteroids", "name": "BETAMETHASONE ESTERS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.4 Topical corticosteroids", "BETAMETHASONE ESTERS"], "cautions": "Cautions\u00a0\n(From 13.4 Topical corticosteroids: British National Formulary)\nCautions\u00a0Avoid prolonged use of a topical corticosteroid on the face (and keep away from eyes). In children avoid prolonged use and use potent or very potent corticosteroids under specialist supervision; extreme caution is required in dermatoses of infancy including nappy rash\u2014treatment should be limited to 5\u20137 days.Psoriasis\u00a0The use of potent or very potent corticosteroids in psoriasis can result in rebound relapse, development of generalised pustular psoriasis, and local and systemic toxicity.; use of more than 100\u00a0g per week\r\nof 0.1% preparation likely to cause adrenal suppression", "side-effects": "Side-effects\u00a0\n(From 13.4 Topical corticosteroids: British National Formulary)\nSide-effects\u00a0Mild and moderately potent topical corticosteroids are associated with few side-effects but care is required in the use of potent and very potent corticosteroids. Absorption through the skin can rarely cause adrenal suppression and even Cushing\u2019s syndrome (section 6.3.2), depending on the area of the body being treated and the duration of treatment. Absorption is greatest where the skin is thin or raw, and from intertriginous areas; it is increased by occlusion. Local side-effects include:spread and worsening of untreated infection;thinning of the skin which may be restored over a period after stopping treatment but the original structure may never return;irreversible striae atrophicae and telangiectasia;contact dermatitis;perioral dermatitis;acne, or worsening of acne or rosacea;mild depigmentation which may be reversible;hypertrichosis also reported.In order to minimise the side-effects of a topical corticosteroid, it is important to apply it thinly to affected areas only, no more frequently than twice daily, and to use the least potent formulation which is fully effective.", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5883.htm", "doses": ["Apply thinly 1\u20132 times daily"]}]